Unlock instant, AI-driven research and patent intelligence for your innovation.

Alpha and beta poly (L asparamide) amino acid derivatives cisplatin macromolecule prodrug, preparation method and use thereof

A technology of asparagine and aspartic acid, applied in the field of alpha, can solve problems such as spacer structure not considered

Inactive Publication Date: 2007-08-01
EAST CHINA NORMAL UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above studies did not consider the structure of the spacer between cisplatin and the carrier, and the influence of the self-assembled structure of the carrier / cisplatin macromolecular complex on the curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Alpha and beta poly (L asparamide) amino acid derivatives cisplatin macromolecule prodrug, preparation method and use thereof
  • Alpha and beta poly (L asparamide) amino acid derivatives cisplatin macromolecule prodrug, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: α, the synthesis of β-poly[L-asparagine] (PA)

[0035] Add 25 grams (0.19mol) of L-aspartic acid powder and 12.5 grams of 85% phosphoric acid in a 500ml round bottom flask, mix well, and react under reduced pressure at 185°C on a rotary evaporator for 3 hours until no more water vapor is produced. until. Add 100mL N, N-dimethylformamide and stir to dissolve the solid matter, then slowly add the obtained solution dropwise into a beaker filled with 500mL water under stirring to obtain a white precipitate, let it stand, pour the supernatant, filter, The solid was washed with water until it became neutral, and dried under vacuum at 60° C. for 24 hours to obtain 17 g of a powdery solid α, β-poly[L-asparagine] prepolymer. Dissolve the prepolymer in 150mL N,N-dimethylformamide, add 0.2g N,N-dicyclohexylcarbodiimide to condense at room temperature for 24 hours, filter, concentrate the filtrate, and precipitate the product with distilled water °C and vacuum dried...

Embodiment 2

[0036] Embodiment 2: α, β, the synthesis of L-asparagine and [α, β, L-(N-hydroxyethyl) asparagine] copolymer (PB)

[0037] Dissolve 8g (82.5mmol) of poly[L-asparagine] in 20mL of N, N-dimethylformamide, and add dropwise 2.5mL (41.3mmol) of ethanolamine in N,N-dimethylformamide under stirring , reacted at room temperature for 2 hours, the reaction mixture was concentrated to 10mL, and the product was precipitated with 40mL of ethanol / ether (volume ratio 1:1) mixed solvent and then vacuum-dried to obtain 8g of white polymer (PB), and the ring-opening rate was measured by NMR 30% (D 2 O is the solvent).

Embodiment 3

[0038] Example 3: α, β, the synthesis of poly(L-aspartic acid) (PI)

[0039] Add 4.5g of polymer PA to 500mL of 0.1mol / L sodium hydroxide aqueous solution, stir and react at room temperature for 1 hour, adjust the pH value of the solution to 5 with 0.1mol / L hydrochloric acid, filter, concentrate to 5mL, and dialyze with twice distilled water After 24 hours, the polymer was precipitated with 30 mL of ethanol / ether (volume ratio 1:1), and dried in vacuo to obtain 3 g of poly(L-aspartic acid) (PI).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a making method and usage of alpha, beta-poly (L-asparagines) amino acid derivant-cisplatin macromolecule fore-drug, which comprises the following steps: blending cisplatin and secondary distill solution of polymer carrier according to different proportions; phosphate under indoor temperature to stir 48h; dialyzing through secondary distill water until the acidified silver nitrate solution doesn't opacify; obtaining the product to treat solid tumor.

Description

technical field [0001] The present invention relates to an α, β-poly(L-asparagine) amino acid derivative-cisplatin macromolecular prodrug, and provides a method for preparing the macromolecular prodrug, nanoscale self-assembled macromolecular prodrug and its application , belongs to the field of biomedical technology. Background technique [0002] Cis-dichlorodiammine platinum (II), referred to as cis-platin (cis-platin), is a periodic non-specific drug that can combine with DNA to form a cross bond, thereby destroying the replication function of DNA. Clinical practice has proved that cisplatin has the characteristics of broad anti-cancer spectrum, strong effect, synergy with various anti-tumor drugs, and no cross-resistance. Large variety, widely used in the treatment of ovarian cancer, prostate cancer, testicular cancer, lung cancer, nasopharyngeal cancer, esophageal cancer, malignant lymphoma, breast cancer, head and neck squamous cell carcinoma, thyroid cancer and other...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/48A61K47/34A61K31/282A61K33/24A61P35/00A61K47/59
Inventor 余家会罗淑芳刘顺英
Owner EAST CHINA NORMAL UNIV